5Ang DS, Wei L, Kao MP, et al. A comparison between Btype natriuretic peptide,global registry of acute coronary events(GRACE) score and their combination in ACS risk stratification [J].Heart, 2009,95(22):1836-1842.
6Vanderheyden M, Vfints C, Verstreken S, et al. B-type natfiuretic peptide as a marker of heart failure:new insights from biochemistry and clinical implication[J].Biomark Med,2010,4(2):315-320.
二级参考文献45
1Kivikko M, Antila S, Eha J, ctal. Pharmacokinctics of Ievosimcndan and its mctabolites during and after a 24-hour continuous infusion in patients with severe heart failure[ J]. Int J Clin Pharmacoi Ther,2002,40(10) :465-471.
2Ghcorghiade M, Tecdink JR, Mebazaa A. Pharmacology of New Agents for Acute Heart Failure Syndromes [ J ]. Am J Cardiol,2005 ,96 :68-73.
3Sonntag S, Sundburg S, Lehtonen LA, et al. The Calcium Sensitizer Levosimendan Improves the Function of Stunned Myocardium After Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Ischemia [ J ]. J Am Coll Cardiol, 2004,43(12) :2177-2182.
4Michaels AD, McKeown B, Kostal M,ct al. Effects of intravenous levosimendan on human coronary vasomotor regulation, leftventricular wall stress, and myocardial oxygen uptake[ J]. Circulation ,2005,111 : 1504-1509.
5Maytin M, Colucci WS. Cardioprotection: A new paradigm in the management of acute heart failure syndromes [J ]. Am J Cardiol,2005,96(Suppl) :26G-31G.
6Adamopoulos, Parissis JT, Iliodromitis EK,et al. Effects of Levosimendan Versus Dobutamine on Inflammatory and Apoptotic Pathways in Acutely Decompensated Chronic Heart Failure [ J]. Am J Cardiol,2006,98( 1 ) :102-106.
7Cleland JG, Nikitin N, McGowan J. Levosimendan: first in a new class of inodilator for acute and chronic severe heart failure[ J]. Expert Rev Cardiovasc Ther,2004,2( 1 ) :9-19.
8McMurray J ,Pfeffer MA. New therapeutic options in congestive heart failure: Part H[J ]. Circulation, 2002, 105 ( 18 ) : 2223 -2228.
9Nieminen MS, Akkila J,Hasenfuss G,et al. Hemodynamic and ncurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure[ J]. J Am Coll Cardiol,2000,36(6) :1903-1912.
10Moiseyev VS,Poder P,Andrejevs N,et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infaretion:a randomized, place bocontrolled, double-blind study ( RUSS- LAN) [J]. Eur Heart J,2002,23(18) :1422-1432.
